Builds a specialized machine used inside chip fabrication lines, sold mainly as equipment to a small set of large semiconductor makers, with parts and service a smaller recurring layer.
- Valued far above the size of its business
- Depends onDownstream position: depends on 12 industries, supplies 6
- ScaleMarket cap is $3.21B, above the global median of $1.18B
- PositionGross margin is 72.6%, higher than 95% of its Specialty Industrial Machinery peers (median 28.3%)
- Interpretations11 currently firing — 11
What this company is and how it runs — written from structure, not news.
At its core, the company coordinates two linked transformations. It manufactures its own high-pressure equipment from mechanical and electrical components and process gases, and that equipment is then used, inside a customer's factory, to treat semiconductor devices with hydrogen or deuterium under high pressure, deactivating defects in them and improving their electrical performance. The company sits downstream of a wide set of supplier industries for its own inputs and feeds into a narrower band of semiconductor-manufacturing industries, coordinating not just the equipment sale but the on-site installation and service work that keeps each machine running at a customer's site.
Revenue comes mainly from one-time sales of the annealing equipment itself, booked when a system is delivered and accepted, with a smaller, more recurring layer from spare parts and maintenance service on machines already installed at customer sites.
As a maker of physical processing equipment, growing output means expanding manufacturing and research space rather than replicating a digital product at near-zero marginal cost, and its recent facility expansion reflects that kind of scaling. Within its current size, it converts an unusually large share of revenue into cash and profit, a pattern that holds consistently across several margin and return measures, and it has been profitable in every year of its financial history on file. CompanyGraph also notes that the value the market currently places on the company sits well above the scale suggested by its recorded financial activity, a gap it flags without judging which figure is correct.
The company draws inputs from a wide base of upstream supplier industries, chiefly mechanical and electrical components and the process gases its equipment uses, though it does not name specific suppliers or disclose where those inputs originate. It manufactures its own equipment rather than depending on a contract manufacturer.
The company sells into a narrow band of semiconductor-manufacturing industries: system-semiconductor and memory-semiconductor makers spanning logic, foundry, NAND flash and DRAM production. A small number of large customers account for most of its revenue, with two identified counterparties together making up a large share of sales, and nearly all of its customers sit outside its home country.
Among the broad population of companies whose growth is capped by how much they can physically produce, this one occupies an unusually narrow position: a single named product line, GENI-SYS, built around a proprietary high-pressure hydrogen annealing process. The company states in its own filings that no competing product exists for that system, though CompanyGraph has not independently verified this, and the company itself says it cannot calculate a precise market-share figure.
The company states that it embeds itself early in customers' technology roadmaps, working alongside their process-development teams on future chip generations before those processes reach production, which it describes as leading customers to choose its equipment again for the next generation. It has also stated that no alternative supplier offers a comparable product, which would limit where a customer could turn even if it wanted to switch. It does not disclose contract lengths or backlog figures that would show how firmly customers are committed at any point in time.
For companies of this general kind, CompanyGraph's default expectation is that growth is limited chiefly by physical production capacity and by the availability of feedstock. This company's own account points to a different limit: it describes its growth as tracking the capital-spending cycles of a small number of large customers, characterizing itself as limited by customer investment demand rather than by its own manufacturing capacity, labor or materials.
Its own disclosures point to concentration as a central vulnerability: a large share of revenue rests on a small number of identified customers, nearly all of its sales originate outside its home currency zone, and it states that its profitability tracks the investment cycles of the semiconductor industry. Among the financial risks it lists, it names currency risk first, ahead of credit and liquidity risk.
Its results move with the capital-spending cycles of a small number of large chip manufacturers: the company states directly that pull-backs in customer investment reduce its revenue. It carries foreign-currency exposure concentrated in the US dollar, since most of its revenue originates outside its home market. It also operates under pressure-vessel safety certification regimes in multiple jurisdictions, and discloses ongoing patent-related legal matters in the ordinary course of business, none of which it describes as brought against it as a defendant.
Read from the company's own filings and public materials (gathered August 2026) together with figures CompanyGraph recomputed from its statements. Written September 2026. A question with no evidence behind it is left out rather than answered.
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
The reported statements, read against the company's own industry.
- Valued far above the size of its business
11 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Three Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion Levels
Its gross margin and its cash margin are high for its industry, and its operating margin is high outright.
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Its gross and net margins are high for its industry, and its operating margin is high outright.
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Structural Tensions
Financial Health
Supply Chain
Scale
Companies that share the same coordination system — how they create, deliver, or capture value.
Companies that share active interpretations — structural patterns currently present in both stocks.